HER2 expression in cervical cancer as a potential therapeutic target
<p>Abstract</p> <p>Background</p> <p>Trastuzumab, a humanized monoclonal antibody against the HER2 receptor is currently being used in breast and other tumor types. Early studies have shown that a variable proportion of cervical carcinoma tumors overexpress the HER2 receptor as evaluated by diverse...
Gorde:
| Egile Nagusiak: | , , , , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
BMC
2004-09-01
|
| Saila: | BMC Cancer |
| Sarrera elektronikoa: | http://www.biomedcentral.com/1471-2407/4/59 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|